Achilles Therapeutics plc - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ACHL Nasdaq 2830 www.achillestx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achilles Therapeutics plc

Achilles Therapeutics sells technology assets to AstraZeneca for $12M - Dec 25th, 2024 2:35 pm
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca - Dec 24th, 2024 2:30 pm
US Penny Stocks To Watch In November 2024 - Nov 19th, 2024 5:04 pm
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market - Nov 19th, 2024 12:00 pm
Achilles Therapeutics Reports Third Quarter 2024 Financial Results - Nov 14th, 2024 12:00 pm
Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year? - Sep 23rd, 2024 1:40 pm
Achilles Therapeutics Announces Strategic Update - Sep 19th, 2024 11:00 am
Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely? - Aug 14th, 2024 4:01 pm
Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - Aug 14th, 2024 11:00 am
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines - May 22nd, 2024 11:00 am
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - May 17th, 2024 9:00 pm
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - May 8th, 2024 11:00 am
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights - Apr 4th, 2024 10:45 am
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning - Apr 4th, 2024 10:30 am
Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year? - Feb 9th, 2024 2:40 pm
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference - Feb 5th, 2024 12:00 pm
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year? - Jan 24th, 2024 2:40 pm